Parallax Volatility Advisers, L.P. Novavax Inc Call Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $84,960 - $135,759	17,700 Added 17.22%	120,500 $578,000
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $700,068 - $1 Million	102,800 New	102,800 $744,000
Q4 2022 Feb 14, 2023	SELL	$8.86 - $25.04 $736,266 - $2.08 Million	-83,100 Reduced 59.06%	57,600 $592,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $2.33 Million - $9.74 Million	128,000 Added 1007.87%	140,700 $2.56 Million
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $5.46 Million - $11.3 Million	-150,500 Reduced 92.22%	12,700 $653,000
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $2.08 Million - $4.27 Million	-29,900 Reduced 15.48%	163,200 $12 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $11.5 Million - $18.7 Million	85,600 Added 79.63%	193,100 $27.6 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $4.23 Million - $6.44 Million	-23,800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $19.1 Million - $29.1 Million	107,500 New	107,500 $22.3 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $2.88 Million - $6.13 Million	23,800 New	23,800 $5.05 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $1.13 Million - $3.2 Million	-10,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $1.13 Million - $3.2 Million	10,000 New	10,000 $1.81 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $3.81 Million - $6.75 Million	-48,400 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $3.84 Million - $8.64 Million	48,400 New	48,400 $5.24 Million
Q1 2020 May 15, 2020	SELL	$3.93 - $16.0 $76,438 - $311,200	-19,450 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $95,888 - $237,290	19,450 New	19,450 $114,000

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account